# B Positive National Blood Services – FDA Inspection, Sep 2, 2026

Source: https://www.keypedia.com/records/fda_inspections/b-positive-national-blood-services/816ab7d6-b85e-495f-b5e1-c43df8fc2c07
Source feed: FDA_Inspections

> FDA inspection 1333964 of B Positive National Blood Services, September 02, 2026. 1 citation under 21 CFR part 606. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1333964
- Company Name: B Positive National Blood Services
- Inspection Date: 2026-09-02
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Philadelphia District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1249785 - 2024-08-22

## Related Officers

- [Michele Gottshall](https://www.keypedia.com/people/michele-gottshall/f12dcaf7-8958-4591-88bb-f9746796b934)

Company: https://www.keypedia.com/companies/b-positive-national-blood-services/3a3bfe54-4c87-4da9-a409-bd5d29f399fa

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8